News
DGAP-News: HELLA GmbH & Co. KGaA: HELLA and Faurecia set the course for a joint future
DGAP-News: Aurubis AG: Aurubis AG steigert operatives Ergebnis im 1. Quartal deutlich und erhöht Gesamtjahresprognose
DGAP-News: Aurubis AG: Aurubis AG considerably boosts operating result in Q1 and increases full-year forecast
Washington Federal Bank Announces Completion of Conversion to Washington State Chartered Commercial Bank
Washington Federal Bank, the wholly owned subsidiary of Washington Federal, Inc. (Nasdaq: WAFD) (the "Company"), today announced the successful completion of its conversion from a national bank
Pioneer Natural Resources Company Issues Notices of Full Redemption for Its 0.750% Senior Notes Due 2024 and 4.45% Senior Notes Due 2026
Pioneer Natural Resources Company (NYSE: PXD) (“Pioneer” or the “Company”) today announced that it has delivered notices of full redemption of all of its outstanding 0.750% Senior Notes due 2024
Brown-Forman Third Quarter Earnings Release and Conference Call Scheduled for March 3, 2022
Brown-Forman Corporation (NYSE: BFA, BFB) will release its third quarter and fiscal 2022 year-to-date financial results on March 3, 2022, by 8:00 a.m. (EST), followed by a conference call to
American Express Chief Financial Officer to Participate in KBW Fintech Payments Conference
American Express Company (NYSE: AXP) Vice Chairman and Chief Financial Officer Jeffrey C. Campbell will participate in the Keefe, Bruyette & Woods (KBW) Fintech Payments Conference in New York on
American Express Chief Financial Officer to Participate in KBW Fintech Payments Conference
American Express Company (NYSE: AXP) Vice Chairman and Chief Financial Officer Jeffrey C. Campbell will participate in the Keefe, Bruyette & Woods (KBW) Fintech Payments Conference in New York on
Blue Bird Announces Price Increases for Type C and D Bus Model Types
Blue Bird Corporation, the leader in electric and low-emission school buses, announced today that it will implement a price increase to offset rising material, freight and labor costs primarily
Kohl’s Board of Directors Provides Update on Review of Unsolicited Expressions of Interest
Kohl’s Corporation (NYSE:KSS) (“Kohl’s” or the “Company”) today issued the following statement:
The Kohl's Board of Directors (the Board) has determined, following a review with its independent
Agilent Highlights Integrated Automation Solutions at SLAS 2022
Agilent Technologies Inc. (NYSE: A) highlights innovative laboratory automation solutions at the SLAS2022 International Conference and Exhibition held February 5 through February 9, 2022, at the
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
DGAP-News: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Einvernehmliche Amtsbeendigung mit Vorsitzendem der Geschäftsführung Dr. Rolf Breidenbach
DGAP-Adhoc: HELLA GmbH & Co. KGaA: Termination of office by mutual agreement with Chairman of the Management Board Dr. Rolf Breidenbach
Eaton Reports Record Fourth Quarter 2021 Results, Guidance on 2022 Outlook
Power management company Eaton Corporation plc (NYSE:ETN) today announced that earnings per share were $1.37 for the fourth quarter of 2021. Excluding charges of $0.23 per share related to
SÜSS MicroTec SE: Dr. Dietmar Meister wird aus dem Aufsichtsrat ausscheiden
SÜSS MicroTec SE: Dr. Dietmar Meister to leave Supervisory Board
DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets
DGAP-Adhoc: Evotec SE: Bayer stellt den klinischen Entwicklungskandidaten Eliapixant (BAY1817080) ein; Evotec erhält Rechte für alle P2X3-Assets zurück
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA and free cash flow for full year 2021 significantly exceed previous outlook
DGAP-Adhoc: K+S Aktiengesellschaft: EBITDA und Freier Cashflow übertreffen im Gesamtjahr 2021 deutlich bisherige Prognose
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 1, 2022, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement